Search research articles
Contact Us
Filters
Showing results (121-130 of 167) with videos related to
Page
of 17
Sort By:
Medical and Veterinary Entomology
|
April 1, 1993
Uptake and fate of specific antibody in feeding larvae of the sheep blowfly, Lucilia cuprina
C H Eisemann, R D Pearson, R A Donaldson, et al.
Lancet (London, England)
|
November 9, 1996
Dosage for malaria treatment
D J Krogstad, R D Pearson, J E Bennett, et al.
The Medical Journal of Australia
|
November 26, 1977
Convulsions in the first three years of life
E J Rossiter, J Luckin, A Vile, et al.
Infection and Immunity
|
June 1, 1986
Susceptibility of Campylobacter jejuni to strain-specific bactericidal activity in sera of infected patients
R A Pennie, R D Pearson, L J Barrett, et al.
Biomedicines
|
August 26, 2023
A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer
Carles Puig-Saenz, Joshua R D Pearson, Jubini E Thomas, et al.
Chest
|
February 1, 1993
Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion
C E Chenoweth, S Singal, R D Pearson, et al.
Insect Biochemistry and Molecular Biology
|
October 1, 1995
Carboxydipeptidase from Boophilus microplus: a "concealed" antigen with similarity to angiotensin-converting enzyme
J M Jarmey, G A Riding, R D Pearson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1982
Failure of the phagocytic oxidative response to protect human monocyte-derived macrophages from infection by Leishmania donovani
R D Pearson, J L Harcus, P H Symes, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 1, 1990
Wasting and macrophage production of tumor necrosis factor/cachectin and interleukin 1 in experimental visceral leishmaniasis
R D Pearson, G Cox, T Evans, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1984
Antileishmanial activity of chlorpromazine
R D Pearson, A A Manian, D Hall, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 167) with videos related to
Sort By:
Page
of 17
Medical and Veterinary Entomology
|
April 1, 1993
Uptake and fate of specific antibody in feeding larvae of the sheep blowfly, Lucilia cuprina
C H Eisemann, R D Pearson, R A Donaldson, et al.
Lancet (London, England)
|
November 9, 1996
Dosage for malaria treatment
D J Krogstad, R D Pearson, J E Bennett, et al.
The Medical Journal of Australia
|
November 26, 1977
Convulsions in the first three years of life
E J Rossiter, J Luckin, A Vile, et al.
Infection and Immunity
|
June 1, 1986
Susceptibility of Campylobacter jejuni to strain-specific bactericidal activity in sera of infected patients
R A Pennie, R D Pearson, L J Barrett, et al.
Biomedicines
|
August 26, 2023
A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer
Carles Puig-Saenz, Joshua R D Pearson, Jubini E Thomas, et al.
Chest
|
February 1, 1993
Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion
C E Chenoweth, S Singal, R D Pearson, et al.
Insect Biochemistry and Molecular Biology
|
October 1, 1995
Carboxydipeptidase from Boophilus microplus: a "concealed" antigen with similarity to angiotensin-converting enzyme
J M Jarmey, G A Riding, R D Pearson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1982
Failure of the phagocytic oxidative response to protect human monocyte-derived macrophages from infection by Leishmania donovani
R D Pearson, J L Harcus, P H Symes, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 1, 1990
Wasting and macrophage production of tumor necrosis factor/cachectin and interleukin 1 in experimental visceral leishmaniasis
R D Pearson, G Cox, T Evans, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1984
Antileishmanial activity of chlorpromazine
R D Pearson, A A Manian, D Hall, et al.
Page
of 17